netFormulary NHS
Bedfordshire and Luton Joint Formulary
Bedford Hospital NHS Trust
Bedfordshire CCG
Luton & Dunstable University Hospital NHS Foundation Trust
Luton CCG

Looking for Alemtuzumab found 4 matches

Formulary BNF Category
  Restricted Drug  Alemtuzumab  (Lemtrada®) Anti-lymphocyte monoclonal antibodies - 08.02.03

Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section MHRA Drug Safety Update: Lemtrada„ (alemtuzumab): updated restrictions and strengthened monitoring requirements following review of serious cardiovascular and immune-mediated reactions (February 2020) (08.02.03)
link in drug section NICE TA312: Alemtuzumab for treating relapsing‑remitting multiple sclerosis (08.02.03)
link in drug section Shared Care Guideline Alemtuzumab for treating relapsing-remitting multiple sclerosis Feb 2020 update (08.02.03)